HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene.

Abstract
Chemotherapy, hormonal therapy, or surgery may cause devastating toxic or other side effects. Androgen receptors (ARs) in the cytoplasm are activated by binding with androgen. Androgen-activated ARs bind to a specific genomic DNA sequence, the androgen-responsive element (ARE), and initiate gene expression at the transcriptional level. Even without androgen activation, ARs may have a role in androgen-refractory prostate cancer. Thus, inhibition of AR activity may have therapeutic value. We applied a genetic reporter of the Dual-Luciferase Assay System to test whether a short double-stranded genomic DNA containing prostate-specific antigen (PSA) ARE sequence as decoy DNA would inhibit the function of activated AR. A 21-mer phosphorothioated PSA ARE decoy DNA was synthesized, with a plasmid vector containing the PSA promoter upstream from a luciferase gene, the reporter gene. The promoter and reporter were co-transfected into a human prostate cancer cell line PC3-M with the aid of Lipofectamin 2000. After 24 hr exposure to androgens, the cells were lysed and luciferase activity measured to determine the ARE decoy inhibitory effect on the function of ARs. Luciferase activity was reduced significantly in the ARE decoy transfected cells but not with inactive control decoy. The results demonstrate that ARE decoy DNA can effectively suppress androgen-activated ARs in prostate cancer cells and indicate the potential utility of decoy DNA for developing a novel therapy for prostate cancer.
AuthorsPengju Zhang, Jianye Zhang, Charles Y F Young, Pai C Kao, Weiwen Chen, Anli Jiang, Lianying Zhang, Qiang Guo
JournalAnnals of clinical and laboratory science (Ann Clin Lab Sci) Vol. 35 Issue 3 Pg. 278-84 ( 2005) ISSN: 0091-7370 [Print] United States
PMID16081584 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Androgen Receptor Antagonists
  • Receptors, Androgen
  • Testosterone
  • Prostate-Specific Antigen
Topics
  • Androgen Receptor Antagonists
  • Cell Line, Tumor
  • Genes, Reporter
  • Humans
  • Male
  • Promoter Regions, Genetic (genetics)
  • Prostate-Specific Antigen (genetics)
  • Receptors, Androgen (metabolism)
  • Response Elements (genetics)
  • Testosterone (pharmacology)
  • Transcriptional Activation
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: